This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: David Gies - Innovator in Therapeutic Antibodies
Introduction
David Gies is a notable inventor based in Southbury, CT (US). He has made significant contributions to the field of therapeutic antibodies, particularly in the development of TPO/EPO mimetic peptides. His work has the potential to impact various diagnostic and therapeutic applications.
Latest Patents
David Gies holds a patent for "Antibodies containing therapeutic TPO/EPO mimetic peptides." This patent features therapeutic antibodies, including TPO mimetic antibodies, and their therapeutically-active fragments. The methods for preparing and using these antibodies and fragments are also included in the patent. These therapeutic antibodies are particularly useful for increasing platelet levels in a subject, showcasing their potential in medical treatments.
Career Highlights
David Gies is currently employed at Alexion Pharmaceuticals, Inc., where he continues to innovate in the field of biotechnology. His work at Alexion has allowed him to collaborate with other experts in the industry, further enhancing the development of therapeutic solutions.
Collaborations
One of his notable coworkers is Jeremy P Springhorn. Their collaboration contributes to the advancement of research and development in therapeutic antibodies.
Conclusion
David Gies is a prominent inventor whose work in therapeutic antibodies is paving the way for new medical treatments. His contributions are vital to the ongoing advancements in biotechnology and therapeutic applications.